- Increasing infertility cases and the advancement of new technologies, such as lensless sperm imaging, are expected to propel the growth of the in-vitro fertilization industry in the forecast period.
- In-Vitro Fertilization Market Size – USD 15.87 Billion in 2019, In-Vitro Fertilization Market Growth - CAGR of 9.1%, In-Vitro Fertilization Industry Trends– High demand from developing nations
VANCOUVER, BC, Sept. 23, 2020 /PRNewswire/ --The Global In-Vitro Fertilization Market is forecast to reach USD 31.97 Billion by 2027, according to a new report by Emergen Research. The growth of the sector is facilitated by rising occurrences of infertility attributable to behavioral improvements, policy measures to have fair insurance schemes, and ongoing efforts by suppliers in the industry. The development of fertility therapies to treat male infertility, such as ICSI, is expected to have a positive impact on market growth. In turn, the provision of genomic testing to deter genetic disorder transfer through in-vitro fertilization (IVF) usage is also projected to push the IVF industry. The increase of IVF treatment has led to more insurance players covering the procedures. It led directly to competitive rates and moderated the costs of IVF treatment, as the process was a successfully mastered technology that has driven the market with more optimization and automation of therapy. The main factor leading to reduced Total Fertility Rate (TFR) is a behavioral change in culture. These factors include a growing number of women in the workforce, higher first-born age, urbanization, lower marriage rates, and changing attitude towards marriage.
Growing consumer understanding of infertility and the development of various therapies are anticipated to fuel business growth. Any other reasons, such as the availability of innovative drugs, decreased male infertility, reduced alcohol & tobacco use, and increased policy efforts to improve IVF care, are projected to further fuel consumer demand.
According to the American Society for Pregnant Medicine (ASRM), approximately 6.7 million people in the U.S. are impacted by the inability to conceive, which accounts for around 11.0% of the reproductive population. Additionally, 25% of couples have more than one factor that can cause infertility. Researchers have also developed methods that are used beforehand to improve the effective rate of in-vitro fertilization. Specific methods such as aided hatching, vitrification, processing of egg/sperm, percutaneous epidydimal sperm accumulation and testicular sperm retrieval (PESA and TESE), mini IVF, tri-parent IVF, and genetic testing are already being utilized. Due to the broad target demographic, low treatment cost than developing countries, and availability of advanced technologies, Asia Pacific held the largest market share with regard to the number of IVF cycles conducted in 2019.
Based on instrument, disposable devices generated a revenue of USD 5.27 billion in 2019 and is estimated to rise with a CAGR of 9.5% in the forecast period. Due to the need for high sterile conditions and strict regulatory requirements, market players are incorporating disposable devices such as needles, slides, and chambers.
The fresh non-donor procedure segment is expected to grow with a CAGR of 9.3% in the forecast period owing to the steady success rate in the first attempt.
The fertility clinic application is the major contributor to the In-Vitro Fertilization Market. The fertility clinics application of the European region is leading the market segment and held around 64.0% of the market in the year 2019. Owing to the growing demands for ART treatments, there is a significant increase in the number of fertility centers and ART centers, which provide counseling for couples with conceiving problems.
Europe dominated the market for In-Vitro Fertilization in 2019 as it became the first to develop the in-vitro fertilization method to delete the controversial title from the cryopreservation of sperm and the first to officially authorize IVF or the mitochondrial fusion strategy of the three parents. The European region held approximately 35.1% of the market, followed by North America, contributing to around 31.0% of the market share in the year 2019.
Key participants include Thermo Fisher Scientific Inc., Irvine Scientific, OvaScience, Cooper Surgical Inc., EMD Serono Inc., Cook Medical Inc., Cardone & Associates Reproductive Medicine & Infertility LLC, Morpheus Life Sciences Pvt. Ltd., Vitrolife AB, and Genea Biomedx, among others.
For the purpose of this report, Emergen Research has segmented the global In-Vitro Fertilization market based on the procedure type, instrument, application, and region:
Procedure Type Outlook (Revenue, USD Billion; 2017-2027)
Instrument Outlook (Revenue, USD Billion; 2017-2027)
Application Outlook (Revenue, USD Billion; 2017-2027)
Regional Outlook (Revenue, USD Billion; 2017-2027)
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East & Africa
Rest of MEA
Find more similar research insights by Emergen Research:
Injectable Drug Delivery Market By Product Type (Formulations, Devices), By Therapeutic Application (Hormonal disorders, Autoimmune disorders, Oncology), By End-User (Homecare settings, Hospitals & Clinics), Forecasts to 2027
Surgical Robotics Market By Types (Neurosurgery, Spinal surgery, ENT Surgery, Orthopedic Surgery, Robotic Radiosurgery System), By Applications (Pediatrics, Adults, Geriatrics), By End Use (Hospitals, Ambulatory Care Centers, Others), and Regions Forecasts to 2027
Animal Genetics Market By Live Animals (Porcine, Bovine, Poultry, Canine and Others), By Genetic Materials (Embryo, Semen) and By Services (Genetic Trait Testing, Genetic Disease Testing, DNA Type Testing) Forecasts to 2027
Women's Health Market By Product Type, By Application (Contraceptives, Postmenopausal Osteoporosis, Hormonal Infertility, Menopause, Endometriosis, Polycystic Ovary Syndrome (PCOS)), By End-Users (Hospitals & Clinics, Obstetrics & Gynecology Centers, Ambulatory Surgical Centers, Research Institutes), Forecasts to 2027
Ventilator Market By Interface (Invasive, Non-Invasive), By Type (Adults/Pediatric, Neonatal/Infants, By Mode (Pressure, Volume, Dual/Combined Mode), By End-Users (Hospitals, Home Care Settings, Ambulatory Care Centers, Emergency Medical Services), Forecasts to 2027
Sports Medicine Market By Product (Body Reconstruction Products, Body Support and Recovery Products), By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries), By Body Monitoring and Evaluation Devices, By End-Use, and By Region, and By Region, Forecasts to 2027
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.